Muscle channelopathies

Handb Clin Neurol. 2023:195:521-532. doi: 10.1016/B978-0-323-98818-6.00006-6.

Abstract

Muscle channelopathies encompass a wide range of mainly episodic conditions that are characterized by muscle stiffness and weakness. The myotonic conditions, characterized predominantly by stiffness, include myotonia congenita, paramyotonia congenita, and sodium channel myotonia. The periodic paralysis conditions include hypokalemic periodic paralysis, hyperkalemic periodic paralysis, and Andersen-Tawil syndrome. Clinical history is key, and diagnosis is confirmed by next-generation genetic sequencing of a panel of known genes but can also be supplemented by neurophysiology studies and MRI. As genetic testing expands, so have the spectrum of phenotypes seen including pediatric presentations and congenital myopathies. Management of these conditions requires a multidisciplinary approach with extra support needed when patients require anesthetics or when pregnant. Patients with Andersen-Tawil syndrome will also need cardiac input. Diagnosis is important as symptomatic treatment is available for all of these conditions but need to be tailored to the gene and variant of the patient.

Keywords: Channelopathy; Chloride channel; Episodic weakness; Myotonia; Periodic paralysis; Sodium channel.

Publication types

  • Review

MeSH terms

  • Andersen Syndrome* / genetics
  • Channelopathies* / genetics
  • Humans
  • Muscle, Skeletal
  • Mutation
  • Myotonic Disorders* / diagnosis
  • Myotonic Disorders* / genetics
  • Paralysis
  • Paralysis, Hyperkalemic Periodic* / genetics